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Abstract
Summary: Tumour evolution results in progressive cancer phenotypes such as metastatic spread
and treatment resistance. To better treat cancers, we must characterize tumour evolution and the
genetic events that confer progressive phenotypes. This is facilitated by high coverage genome or
exome sequencing. However, the best approach by which, or indeed whether, these data can be
used to accurately model and interpret underlying evolutionary dynamics is yet to be confirmed.
Establishing this requires sequencing data from appropriately heterogeneous tumours in which
the exact trajectory and combination of events occurring throughout its evolution are known. We
therefore developed HeteroGenesis: a tool to generate realistically evolved tumour genomes,
which can be sequenced using weighted-Wessim (w-Wessim), an in silico exome sequencing tool
that we have adapted from previous methods. HeteroGenesis simulates more complex and realis-
tic heterogeneous tumour genomes than existing methods, can model different evolutionary dy-
namics, and enables the creation of multi-region and longitudinal data.
Availability and implementation: HeteroGenesis and w-Wessim are freely available under the
GNU General Public Licence from https://github.com/GeorgetteTanner, implemented in Python and
supported on linux and MS Windows.
Contact: l.f.stead@leeds.ac.uk
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
The evolution of a tumour affects its clinical course: malignant phe-
notypes undergo selection resulting in increased growth, invasion,
metastases or therapy resistance. Elucidating the mode and course of
tumour evolution therefore impacts upon our understanding of dis-
ease progression and how to more effectively treat patients
(Amirouchene-Angelozzi et al., 2017). Characterizing suitable mod-
els of tumour evolution and testing our ability to identify them from
observable sequencing data requires datasets from tumours where
the subclonal architecture and mutational events that define them
are completely known; i.e. it requires sequencing data from realistic-
ally simulated, suitably heterogeneous tumours (Sun et al., 2017;
Williams et al., 2016, 2018). Numerous tumour genome simulation
tools exist (see Supplementary Material), but they lack the ability to
recreate the complexity inherent in real data as they do not model
certain phenomena known to occur through actual tumour
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evolution, such as: (i) multi-level subclone phylogenies, (ii) individ-
ual chromosome and whole-genome aneuploidy, (iii) overlapping
copy number variants (CNVs)— either nested within the same
chromosome copy, or partially or fully overlapping the same
region on different copies, (iv) variants occurring in a flexible order
and (v) distinct germline and somatic variants (see Supplementary
Table S1).
To address these shortcomings, we developed HeteroGenesis: a
simulator of genomes from realistically heterogeneous tumours that
can result from varied and user-determined evolutionary trajecto-
ries. We also improved an in silico whole exome sequencing (WES)
tool, Wessim (Kim et al., 2013; McElroy et al., 2012), and provide
this as weighted-Wessim (w-Wessim). Together, these tools create
sequencing data and ‘ground truth’ variant profiles for simulated
bulk tumour samples, which can include ‘normal’ contamination
and be manipulated to model multi-region and longitudinal
sampling.
2 Implementation and workflow
2.1 HeteroGenesis
HeteroGenesis consists of three consecutive python programmes
(Supplementary Box S1 and Fig. S1); heterogenesis_vargen generates
lists of variants (single nucleotide variants [SNVs], insertions/dele-
tions [InDels], CNVs [with or without inversion] and aneuploid
events) to be incorporated into the genomes for each clone in a tu-
mour, along with a matched germline. It takes as input: (i) a refer-
ence FASTA genome sequence, (ii) an optional file containing
known germline SNV and InDel locations and minor allele frequen-
cies formatted from dbSNP and (iii) a JSON file containing a set of
parameters. It outputs a JSON file with lists of variants for each
clone in the simulated tumour and a matched germline, as well as
files containing the order that mutations occurred. heterogenesis_-
varincorp is run separately for each clone, and the germline sample.
It takes the lists of variants generated by heterogenesis_vargen and
incorporates them into the reference genome sequence, as well as
calculating copy numbers and variant frequencies along the genome.
freqcalc is then run to combine variant profiles for individual clones
from heterogenesis_varincorp outputs to describe one or more bulk
samples.
Further details are included in the Supplementary Material and
Supplementary Figures S2–S4. HeteroGenesis is freely available at
https://github.com/GeorgetteTanner/HeteroGenesis.
2.2 w-Wessim
We adapted the only existing in silico WES tool, Wessim (Kim et al.,
2013; McElroy et al., 2012), to create w-Wessim, and combine it
with an altered protocol. This includes, among others (see
Supplementary Material), two significant improvements;
2.2.1 Weighted probe selection
Wessim aims to mimic exome capture, during sequencing library
preparation, through the use of BLAT (Kent, 2002) alignments of
capture probe (primer) sequences to a genome in order to define
regions for sequencing. However, the programme selects probes
at random for in silico hybridization each time it creates a read,
negating the modelling of copy number variation. We modified
the code to weight probe selection by the number of times each
probe aligns to a genome, thereby increasing the coverage in
replicated regions.
2.2.2 Probe sequences taken from real WES reads
The use of exome capture kit probes for in silico sequencing results
in unrealistic read coverage distributions (Supplementary Fig. S5).
Instead we provide a set of probes taken from reads in real WES
data and show that this approach results in a more realistic distribu-
tion of generated reads.w-Wessim is freely available from https://
github.com/GeorgetteTanner/w-wessim.
3 Discussion
3.1 HeteroGenesis
We developed HeteroGenesis to simulate genomes for multiple
clones in a heterogeneous tumour, along with a matched germline.
When compared with previous methods, HeteroGenesis has several
significant improvements to allow it to recreate much of the com-
plexity observed in real tumours (see Supplementary Material). In
particular, the user has full control over the phylogenetic relation-
ships between clones and, therefore, varied and complex evolution-
ary trajectories can be modelled (Supplementary Box S1).
Following tumour genome simulation, freqcalc can be used to
combine variant information generated for each subclone to give
overall bulk outputs that reflect user defined proportions of each
clone in a sample. This is useful, for example, when testing how
sampling affects the ability of subclonal deconvolution pipelines to
elucidate different evolutionary trajectories from known ground
truths. Moreover, this approach can: (i) include simulated germline
sequencing data to mimic the contamination of normal cells in a tu-
mour sample, (ii) create multiple bulk datasets from the same tu-
mour with different proportions of clones to mimic multi-region
sampling, an approach that enables more reliable delineation of sub-
clone architectures (Sun et al., 2017) and (iii) create multiple bulk
datasets with different combinations of clones to represent longitu-
dinal samples. An example of this is given in Supplementary Box 1.
3.2 w-Wessim
We sought a tool to enable in silico WES of our simulated genomes
and were only able to identify Wessim for this purpose (Kim et al.,
2013; McElroy et al., 2012). However, Wessim is not able to model
copy number variation (Supplementary Fig. S5B), so we adapted it
to create w-Wessim, which, through weighting probe selection by
the number of times each is found to align to the genome, results in
accurate modelling of copy number variation (Supplementary Fig.
S5C).
We also aimed to improve the distributions of reads created by
w-Wessim/Wessim to more realistically model WES data. Exon cap-
ture kits do not result in a perfect enrichment for only target regions,
with only around 65% of reads aligning on-target (Supplementary
Material). However, w-Wessim/Wessim result in very high propor-
tions of bases aligning on or near target regions when used with
probe sequences from the Agilent SureSelect Human All Exon
V4þUTRs kit and default BLAT parameters; 90.6 and 90.0% on
target and 99.6 and 98.1% on or near target for w-Wessim and
Wessim, respectively (Supplementary Fig. S6A). Furthermore, the
mode coverage in three real WES datasets that used the V5þUTRs
kit, each with 70m reads, was 8x-29x, whereas the mode coverage
for the same number of reads from w-Wessim and Wessim, using
the V4þUTRs kit probes (the V5 probe sequences were not publi-
cally available), was 66x and 80x (Supplementary Fig. S6B).
We overcame this using read sequences from real WES data
(with 75.8% of bases on or near target) as the probes in the BLAT
alignment. By filtering these reads for those with a high alignment
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mapping score and adjusting the stringency of the BLAT align-
ment, we are able to generate reads with w-Wessim that match the
distribution of reads seen in the real data, with 79.7% of bases
aligning on or near target and a mode coverage of 28x
(Supplementary Figs S5 and S6). A demonstration of the combined
use of HeteroGenesis and w-Wessim is provided in Supplementary
Figures S7 and S8.
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